Nutriband Temettü
Temettü kriter kontrolleri 0/6
Nutriband does not have a record of paying a dividend.
Anahtar bilgiler
n/a
Temettü verimi
-12.8%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | -12.8% |
| Gelecekteki Temettü Verimi | n/a |
| Temettü Büyümesi | n/a |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | n/a |
| Ödeme oranı | n/a |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
Is Nutriband (NASDAQ:NTRB) A Risky Investment?
Mar 31
Is Nutriband (NASDAQ:NTRB) Weighed On By Its Debt Load?
Sep 13Nutriband GAAP EPS of -$0.12, revenue of $0.5M
Sep 08Nutriband opens a new branch in Ecuador with plans to expand into the South American market
Jul 22Nutriband: Advancing Transdermal Delivery Of Injectable Drugs
Nov 01Does Nutriband (NASDAQ:NTRB) Have A Healthy Balance Sheet?
Oct 06Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Insufficient data to determine if NTRB's dividends per share have been stable in the past.
Büyüyen Temettü: Insufficient data to determine if NTRB's dividend payments have been increasing.
Piyasaya Karşı Temettü Getirisi
| Nutriband Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (NTRB) | n/a |
| Pazarın Alt %25'i (US) | 1.5% |
| Pazarın En İyi %25'i (US) | 4.5% |
| Sektör Ortalaması (Pharmaceuticals) | 2.3% |
| Analist tahmini (NTRB) (3 yıla kadar) | n/a |
Önemli Temettü: Unable to evaluate NTRB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Yüksek Temettü: Unable to evaluate NTRB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Insufficient data to calculate NTRB's payout ratio to determine if its dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as NTRB has not reported any payouts.